All Life sciences articles – Page 5
-
News
LXi REIT acquires life science campus in York
Specialist inflation-protected long income REIT invests £80m in three deals
-
News
TIAA buys life-sciences portfolio as IRA Capital offloads $620m of assets
Nuveen launches US Cities Office Fund with purchase of 27 healthcare assets
-
News
Madison International backs AXA IM Alts’s European life-sciences platform
Investment in Kadans platform follows last year’s investment in US specialist IQHQ
-
News
AXA IM Alts raises €1.9bn for European life science real estate fund
The AXA European Life Science Strategy fund will be built around the Kadans platform
-
News
CPP Investments, Greystar create US life science real estate development JV
Newly created joint venture plan to invest an initial $1.2bn in development opportunities
-
News
Ivanhoé Cambridge, Lighthouse invest in life science offices in India
Canadian investor expects India to ’further cement its position in the global life science arena in the post-pandemic world’
-
NewsOhio SERS seeks data centres, life science office investments
US pension fund believes non-traditional offices offer higher rent growth prospects
-
NewsFlorida SBA pays $177m for California life science asset
The 173,757sqft Brittan West building project is expected to be completed in two years
-
News
Investors rush to join €750m fundraise for AXA life-sciences real estate fund
Oversubscribed AXA European Life Science Strategy to expand Kadans platform acquired last year
-
News
BentallGreenOak makes UK life science acquisitions via new JV
MSci partnership seeks to expand presence in the UK’s growing life sciences and innovation sectors
-
News
Oxford Properties to deploy £1.2bn in Europe life science push
Marks entry into European life science real estate sector with acquisition of 310 Cambridge Science Park
-
News
Charter Hall Australia industrial fund buys A$106m life sciences campus
GSK sells asset in Melbourne suburb of Boronia to CPIF in sale and leaseback deal
-
Special ReportsHealthcare & life sciences
The healthcare and life-sciences real estate sectors are booming. Such is the need for specialist space from life-sciences companies, real estate investors are racing to keep up with demand. In this report, we look at how investment and innovation during the pandemic have been transforming these industries and explore what this means for the real assets investors globally.
-
Special ReportsLife-sciences real estate: The US lab space race
The US real estate market cannot keep pace with the demand for specialist space from life-sciences tenants. Stephanie Schwartz-Driver reports
-
Special ReportsLife-sciences real estate: European markets test positive
The life-sciences real estate market is growing fast in the UK and in continental Europe. Vanessa Drucker reports
-
AnalysisViewpoint: Opportunity to capitalise on life-sciences growth
Research into the life-sciences sector by ULI Europe shows the obstacles and opportunities for real estate investors
-
News
Harrison Street, Trinity's UK life science real estate JV buys BioCity
JV’s £120m deal creates £450m labs and offices business covering nine locations
-
News
AEW buys Danish life science asset for core European property fund
Open-ended Eurocore fund buys the Sydmarken 5 asset in the Medicon Valley of Copenhagen
-
News
L&G, Bruntwood UK JV buys £46m life science hub in Cambridge
Bruntwood SciTech buys 16.4-acre site from TTP
-
AnalysisLife-sciences real estate: More than an experiment
The surge in investment in life-sciences property in 2020 was not all about COVID-19, writes Rachel Fixsen
